Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors

被引：1
作者：
Saussele, S. [1 ]
Hehlmann, R. [1 ]
Gratwohl, A. [2 ]
Hochhaus, A. [3 ]
机构：
[1] Univ Heidelberg, Med Fak Mannheim, D-6800 Mannheim, Germany
[2] Univ Klinikum Basel, Basel, Switzerland
[3] Univ Klinikum Jena, Jena, Germany
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷 / 02期
关键词：
CHRONIC MYELOID-LEUKEMIA; ALLO-SCT;
D O I：
10.1038/bmt.2011.70
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：304 / 304
页数：1
相关论文
共 5 条
  • [1] Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
    Baccarani, Michele
    Cortes, Jorge
    Pane, Fabrizio
    Niederwieser, Dietger
    Saglio, Giuseppe
    Apperley, Jane
    Cervantes, Francisco
    Deininger, Michael
    Gratwohl, Alois
    Guilhot, Francois
    Hochhaus, Andreas
    Horowitz, Mary
    Hughes, Timothy
    Kantarjian, Hagop
    Larson, Richard
    Radich, Jerald
    Simonsson, Bengt
    Silver, Richard T.
    Goldman, John
    Hehlmann, Rudiger
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 6041 - 6051
  • [2] Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia
    Hehlmann, Ruediger
    Berger, Ute
    Pfirrmann, Markus
    Heimpel, Hermann
    Hochhaus, Andreas
    Hasford, Joerg
    Kolb, Hans-Jochem
    Lahaye, Tanja
    Maywald, Ole
    Reiter, Andreas
    Hossfeld, Dieter K.
    Huber, Christoph
    Loeffler, Helmut
    Pralle, Hans
    Queisser, Wolfgang
    Tobler, Andreas
    Nerl, Christoph
    Solenthaler, Max
    Goebeler, Mariele E.
    Griesshammer, Martin
    Fischer, Thomas
    Kremers, Stephan
    Eimermacher, Hartmut
    Pfreundschuh, Michael
    Hirschmann, Wolf-Dietrich
    Lechner, Klaus
    Wassmann, Barbara
    Falge, Christiane
    Kirchner, Hartmut H.
    Gratwohl, Alois
    [J]. BLOOD, 2007, 109 (11) : 4686 - 4692
  • [3] Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
    Milojkovic, Dragana
    Nicholson, Emma
    Apperley, Jane F.
    Holyoake, Tessa L.
    Shepherd, Pat
    Drummond, Mark W.
    Szydlo, Richard
    Bua, Marco
    Foroni, Letizia
    Reid, Alistair
    Khorashad, Jamshid S.
    de Lavallade, Hugues
    Rezvani, Katy
    Paliompeis, Christos
    Goldman, John M.
    Marin, David
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02): : 224 - 231
  • [4] Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV
    Saussele, Susanne
    Lauseker, Michael
    Gratwohl, Alois
    Beelen, Dietrich W.
    Bunjes, Donald
    Schwerdtfeger, Rainer
    Kolb, Hans-Jochem
    Ho, Anthony D.
    Falge, Christiane
    Holler, Ernst
    Schlimok, Guenter
    Zander, Axel R.
    Arnold, Renate
    Kanz, Lothar
    Dengler, Robert
    Haferlach, Claudia
    Schlegelberger, Brigitte
    Pfirrmann, Markus
    Mueller, Martin C.
    Schnittger, Susanne
    Leitner, Armin
    Pletsch, Nadine
    Hochhaus, Andreas
    Hasford, Joerg
    Hehlmann, Ruediger
    [J]. BLOOD, 2010, 115 (10) : 1880 - 1885
  • [5] Role of allo-SCT for CML in 2010
    Venepalli, N.
    Rezvani, K.
    Mielke, S.
    Savani, B. N.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 (11) : 1579 - 1586
1